🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔬Investigadores del Barcelonaβeta Brain Research Center, nuestro centro de investigación, y el HMar Research Institute, en colaboración con Uni of Gothenburg, Lund University y Brescia University, validan la capacidad de un nuevo biomarcador en sangre para predecir el riesgo de Alzheimer. fpmaragall.org/noticias/un-an…

So proud of Barcelonaβeta Brain Research Center and BioFINDER teams for this very important work on validating an easily-available plasma biomarker for #Alzheimer's diagnosis. Special kudos to my PhD student Noëlle Warmenhoven, co-first author of the paper👏👏👏

New manuscript alert! Can blood-based biomarkers measured on a fully automated platform accurately identify Alzheimer’s disease (AD) pathology?🩸 Our new multi-cohort study has now been published in Nature Medicine: nature.com/articles/s4159…. A thread🧵

📢Our latest study, now published in Nature Medicine , explores the potential of blood biomarkers on an automated platform to detect #Alzheimers . Plasma p-tau217 showed remarkable accuracy, with AUCs ranging from 0.93-0.96! 🩸🧠 Read more here: nature.com/articles/s4159…

Buscamos neurólogos/as para unirse a Barcelonaβeta Brain Research Center Fundación Pasqual Maragall 🧠👩🏻‍⚕️ ➡️estudios observacionales, ensayos clínicos ➡️investigación (con opciones de PhD y postdoc), ➡️actividad clínica en Hospital del Mar Aplica en el enlace👇 barcelonabeta.org/es/centro-inve…

Plasma eMTBR-tau243 is a specific #biomarker of #tau tangles in #Alzheimer’s disease and enables the detecting and tracking of Alzheimer’s clinical impairment. #NeurodegenerativeDiseases #AlzheimersAwareness #Biomarkers nature.com/articles/s4159…

Among 1,767 patients in 5 centers, a fully automated blood test showed high accuracy for Alzheimer’s pathology in secondary and primary care using a predefined cutoff. nature.com/articles/s4159…

Lecanemab has been approved in Europe—the first disease-modifying treatment for #Alzheimer . Now, from public health centers, we must ensure equitable access, minimize risks, and offer the best care. 🧠🏥💚 Barcelonaβeta Brain Research Center Fundación Pasqual Maragall Hospital del Mar ec.europa.eu/newsroom/sante…

This is an impressive work about biological drivers of tau burden and patterns of deposition. Way to go Caly Yu Xiao (肖燏) 💪

The field is moving from only assessing the presence of #Alzheimer's pathology to better categorising patients into different disease stages. Way to go to advance towards precision medicine.

So happy for Emma Coomans for this big accomplishment! Looking forward to seeing your talk. Please help her recommending the best neuroimaging papers of the year.

First of many after works of the Neuroimaging group. Happy to see this team growing. Barcelonaβeta Brain Research Center

Today, Noëlle Warmenhoven did a brilliant presentation during her half-time seminar showing her work in the first two years of her PhD. Well done!💪 Much more to come!

Another impressive presentation today from Linnea Briggner defending her bachelor project as a pro. Best of luck on your next endeavours, I'm sure you'll do great things!🎉

Between 22% and 44% of dementia cases by age 80 are attributed to midlife and late-life vascular risk factors, according to this cohort study. ja.ma/4mGrnxG

Our most important paper, out now! A massive international collaboration, led by Alexis Moscoso Rial, featuring over 6500 visually assessed tau PET scans covering the #Alzheimers spectrum! Thank you very much to the numerous contributors and collaborators who made this gem possible.

Yesterday, Anika brilliantly defended her PhD thesis on the fole of MTL in Alzheimer’s disease. It was a brilliant discussion with Jonathan Schott between peers. Congratulations Dr. Wuestefeld! You did a great job👏👏👏

🚨 Heading to European Association of Nuclear Medicine (EANM) meeting in Barcelona this fall? Don’t miss our special session on the future of PET imaging in the era of emerging Alzheimer’s disease treatments. Join the discussion on what’s next and why it matters #EANM2025 #Neuroimaging #Alzheimers